Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'Leveraging AS01-induced immune cell reprogramming to modulate immune dysregulation in rheumatoid arthritis'. The following are the other relevant details related to the trial:
Therapeutic Area: Infectious Diseases
Trial Centre(s):
Singapore General Hospital
Trial Status: NA
Principal Investigator(s):
Dr Chan Yuen Yue Candice
Published by HT Digital Content Services with permission from Health Daily Digest....